Covid vaccines help AstraZeneca sales jump 50% in third quarter
AstraZeneca has revealed that revenues jumped by 50% in the latest quarter as it was buoyed by more than 1 billion dollars worth of Covid-19 vaccine sales.
The pharmaceutical company held firm on its earnings guidance for the year as it hailed “strong revenue growth and exceptional pipeline delivery”.
The Business Hub
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.




